Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: Do all patients benefit from waiting longer than 6 weeks?

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 5, 2012, Pages 1159-1165

  Perez, Rodrigo O ^a,b   Habr Gama, Angelita ^b   São Julião, Guilherme P ^a   Gama Rodrigues, Joaquim ^b   Sousa Jr , Afonso H S ^a   Campos, Fabio Guilherme ^a   Imperiale, Antonio R ^a   Lynn, Patricio B ^b   Proscurshim, Igor ^b   Nahas, Sergio Carlos ^a   Ono, Carla Rachel ^a,c   Buchpiguel, Carlos Alberto ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Angelita and Joaquim Gama Institute   (Brazil)

^c Hospital Do Coração   (Brazil)

Author keywords

Assessment; CT; Interval; Neoadjuvant chemoradiation therapy; PET; Rectal cancer

Indexed keywords

ASSESSMENT; CT; INTERVAL; NEOADJUVANT CHEMORADIATION; RECTAL CANCER;

COMPUTERIZED TOMOGRAPHY; DISEASES; FLUORINE; GLUCOSE; POLYETHYLENE TEREPHTHALATES; POSITRON EMISSION TOMOGRAPHY; TUMORS;

PATIENT TREATMENT;

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER PATIENT; CANCER THERAPY; CHEMORADIOTHERAPY; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; RECTUM CANCER; RECTUM CARCINOMA; TREATMENT RESPONSE; TUMOR REGRESSION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; ALGORITHMS; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; REGRESSION ANALYSIS; REMISSION INDUCTION; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84869141639     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.01.096     Document Type: Article

References (20)

1. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
2. S. Supiot, J. Bennouna, and E. Rio Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer Colorectal Dis 8 2006 430 435
3. Y. Francois, C.J. Nemoz, and J. Baulieux Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial J Clin Oncol 17 1999 2396
4. A. Habr-Gama, R.O. Perez, and J. Sabbaga Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period Dis Colon Rectum 52 2009 1927 1934
5. M.F. Kalady, L.F. de Campos-Lobato, and L. Stocchi Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer Ann Surg 250 2009 582 589
6. H. Tulchinsky, E. Shmueli, and A. Figer An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer Ann Surg Oncol 15 2008 2661 2667
7. F.A. Calvo, M. Domper, and R. Matute 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation Int J Radiat Oncol Biol Phys 58 2004 528 535
8. C. Capirci, D. Rubello, and F. Pasini The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery Int J Radiat Oncol Biol Phys 74 2009 1461 1469
9. C. Kristiansen, A. Loft, and A.K. Berthelsen PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer Dis Colon Rectum 51 2008 21 25
10. J.G. Guillem, H.G. Moore, and T. Akhurst Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer J Am Coll Surg 199 2004 1 7
11. R.O. Perez, A. Habr-Gama, and J. Gama-Rodrigues Accuracy of PET/CT and clinical assessment in the detection of complete rectal tumor regression following neoadjuvant chemoradiation. long-term results of a prospective trial (NCT00254683) Cancer 2011 10.1002/cncr.26644 Epub ahead of print
12. A. Habr-Gama, R.O. Perez, and G. Wynn Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization Dis Colon Rectum 53 2010 1692 1698
13. A. Habr-Gama, R.O. Perez, and W. Nadalin Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results Ann Surg 240 2004 711 718
14. O. Dworak, L. Keilholz, and A. Hoffmann Pathological features of rectal cancer after preoperative radiochemotherapy Int J Colorectal Dis 12 1997 19 23
15. S.B. Lim, H.S. Choi, and S.Y. Jeong Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers Ann Surg 248 2008 243 251
16. R.O. Perez, G.P. Sao Juliao, and A. Habr-Gama The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer Dis Colon Rectum 52 2009 1137 1143
17. K.L. Berger, S.A. Nicholson, and F. Dehdashti FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features AJR Am J Roentgenol 174 2000 1005 1008
18. M. Maas, P.J. Nelemans, and V. Valentini Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 2010 835 844
19. X.L. Lan, Y.X. Zhang, and Z.J. Wu The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions Clin Radiol 63 2008 756 764
20. H. Zhuang, M. Pourdehnad, and E.S. Lambright Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes J Nucl Med 42 2001 1412 1417